Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma
暂无分享,去创建一个
W. Guo | K. Man | Ning Wang | Yibin Feng | Chien-Shan Cheng | M. Hong | Sha Li | H. Tan | Zhen Chen
[1] You-hong Jiang,et al. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway , 2017, Cellular Physiology and Biochemistry.
[2] Alan D. Lopez,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.
[3] Zhuo-wei Hu,et al. The regulation of β-catenin activity and function in cancer: therapeutic opportunities , 2017, Oncotarget.
[4] G. Santoni,et al. Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition. , 2016, Food & function.
[5] M. Daglia,et al. The potential role of mangiferin in cancer treatment through its immunomodulatory, anti‐angiogenic, apoptopic, and gene regulatory effects , 2016, BioFactors.
[6] Alyssa Fernandez,et al. Mangiferin and Cancer: Mechanisms of Action , 2016, Nutrients.
[7] M. Yuen,et al. IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma , 2016, Oncotarget.
[8] J. Waisberg,et al. Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma. , 2015, World journal of hepatology.
[9] Junjian Zhang,et al. Mangiferin regulates proliferation and apoptosis in glioma cells by induction of microRNA-15b and inhibition of MMP-9 expression. , 2015, Oncology reports.
[10] J. Yang,et al. Mangiferin induces cell cycle arrest at G2/M phase through ATR-Chk1 pathway in HL-60 leukemia cells. , 2015, Genetics and molecular research : GMR.
[11] Y. Xiong,et al. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. , 2015, Molecular cell.
[12] Yue Ma,et al. LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal , 2014, Tumor Biology.
[13] E. Toska,et al. WT1 regulates the development of the posterior taste field , 2014, Development.
[14] Miran Kim,et al. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. , 2013, Journal of hepatology.
[15] Wei Cheng,et al. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. , 2013, Toxicology and applied pharmacology.
[16] Joshua Brody,et al. β-Catenin-Independent Activation of TCF1/LEF1 in Human Hematopoietic Tumor Cells through Interaction with ATF2 Transcription Factors , 2013, PLoS genetics.
[17] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[18] S. Safe,et al. MicroRNA-26b Represses Colon Cancer Cell Proliferation by Inhibiting Lymphoid Enhancer Factor 1 Expression , 2013, Molecular Cancer Therapeutics.
[19] Motoko Sasaki,et al. Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C , 2013, Clinical Cancer Research.
[20] Xi He,et al. Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. , 2012, Cold Spring Harbor perspectives in biology.
[21] M. Waterman,et al. TCF/LEFs and Wnt signaling in the nucleus. , 2012, Cold Spring Harbor perspectives in biology.
[22] Y. Jeng,et al. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion. , 2012, Carcinogenesis.
[23] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[24] D. Rimm,et al. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. , 2011, Cancer cell.
[25] L. Trusolino,et al. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils , 2011, EMBO molecular medicine.
[26] H. Koga,et al. Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. , 2011, Experimental cell research.
[27] V. Huff,et al. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene , 2011, Nature Reviews Cancer.
[28] Xi He,et al. Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.
[29] Marc Ladanyi,et al. WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis , 2009, Cell.
[30] Jared M Flatow,et al. An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1 , 2009, Proceedings of the National Academy of Sciences.
[31] S. Altekruse,et al. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] X. Wang,et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.
[33] J. Prieto,et al. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. , 2009, Cancer research.
[34] Qian He,et al. Major Mango Polyphenols and Their Potential Significance to Human Health. , 2008, Comprehensive reviews in food science and food safety.
[35] F. Trevisani,et al. Recent advances in the natural history of hepatocellular carcinoma. , 2008, Carcinogenesis.
[36] E. Yu,et al. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. , 2008, Journal of hepatology.
[37] M. Konstadoulakis,et al. Strategies for the management of hepatocellular carcinoma , 2007, Nature Clinical Practice Oncology.
[38] L. Attisano,et al. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] Rudolf Grosschedl,et al. Modulation of Transcriptional Regulation by LEF-1 in Response to Wnt-1 Signaling and Association with β-Catenin , 1998, Molecular and Cellular Biology.
[40] Peng Li,et al. Mangiferin inhibition of proliferation and induction of apoptosis in human prostate cancer cells is correlated with downregulation of B-cell lymphoma-2 and upregulation of microRNA-182. , 2016, Oncology letters.
[41] Yu Luo,et al. Mangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[42] S. Fan,et al. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. , 2001, Cancer.